Mandate

Vinge advises Fidelio Capital in connection with acquisition of BioMedtrix

March 18, 2020 M&A

Vinge has advised Fidelio Capital on the acquisition of BioMedtrix, LLC. BioMedtrix is a leading company within the market for veterinary orthopedic implants and instruments.

The company is based in New Jersey, USA, and sells its products to over 35 markets world-wide.

Vinge’s team consisted of, among others, Jonas Bergström and Manne Bergström.

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026